Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NWBO is in control of NWBO Limited since January 19th. 2024.
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) April 19, 2024
Control transferred 3 months ago!!!
Northwest Biotherapeutics Limited and Revimmune Inc shares a funny same address.
J Kelly Ganjei and Philippe Pire "attached".
Revimmune Limited is a "sleeper agent". pic.twitter.com/BtJ1ZSnXqe
I think green retail are waking up noticing how all the concerns are ignored by the disciples.
An admitted liar being critical of a passionate investor. yes he posts alot and ties anything and everything to NWBO and DCVAX BUT he isn't a compulsive liar so he still gets my respect. I do not care how many logins you control and how large your made up NWBO position is, you are pathetic.
You can brag to someone else whatever your record is. I am so insensitive to your stuff. Yes, I post often. Do I post nonsense? You are trying to put everything about DCVax-L into the frame of your mediocre mindset. I haven't seen anything genuine and seminal from your posts.
It’s never good to boast about loading at low because with NWBO you always get opportunity to load lower
I have no advanced knowledge but it seems to me the MHRA is saying a big fat NO!
Just my very humble opinion
Now I am starting to think you are delusional. You tie anything and everything to DCVax and post way too often. Making yourself, at times, look stupid.
Just because I prefer to stay liquid, and I think people are being OVERLY paranoid and delusional (see above) and prefer to tie up their shares because they dont believe Fidelity,etc will honor the shares on NW that were purchased in a cash account, doesn't make me a wolf. If NW spikes Monday, I prefer to have the option to sell, in a instant if I feel so inclined to do so. Its my money, and I dont like roadblocks. I dont need to tie up my shares with all these added steps. I trust Fidelity and all my shares are in a cash account, I never use margin. I talked to a supervisor on the trading desk many times when I had over $14M in Nvidia shares about my shares being lent out. He said they don't do business like that with cash accounts. I trusted Fidelity 100%. I sold everyone of those shares, at different points in time, with zero issues. Even during times when Citron, etc were shorting NVDA heavily.
For the record I probably own more shares of NW than 80% of the posters on here. But believe what you will. Its a free Country.
Market cap propped up. If that MHRA news isn't stellar, they'll wake up to a 5 cent stock before the market even opens. Watch and learn.
Why aren't Hoffscam and Cheese danish buying these cheap shares?
49, 49 , 49, do I hear 49.... c'mon folks. 49, 49,.... SOLD..
Do I hear 48, 48 48......? SOLD!
47 , 47, 47, blabalalanana 47....
LP to LG..... Get in there and sell Mortimer!!!!
You meant droppig
Steadily dropping - not even a $0.50 cent offer anymore
OUCH
Let's see if lately BPs are trying to hire people with expertise on transcriptomic study.
Merck
Senior Scientist, Data-Rich Experimentation
https://www.pharmadiversityjobboard.com/job/senior-scientist-data-rich-experimentation-12541008
Roche
Scientist 3, Translational Oncology
https://roche.wd3.myworkdayjobs.com/en-US/ROG-A2O-GENE/job/Scientist-3--Translational-Oncology_202403-106853-1
Bristol-Myers Squibb
Scientist, Oncogenesis Translational IPS
https://www.talentify.io/job/scientist-oncogenesis-translational-ips-princeton-new-jersey-bristol-myers-squibb-r1578906
AstraZeneca
Postdoctoral Fellow - Profiling the tumor microenvironment using interpretable AI through single cell spatial transcriptomics data
https://www.linkedin.com/jobs/view/postdoctoral-fellow-profiling-the-tumor-microenvironment-using-interpretable-ai-through-single-cell-spatial-transcriptomics-data-at-astrazeneca-3853074207/
GSK
Associate Director, Oncology Genomics
https://jobs.gsk.com/en-gb/jobs/393821
Gilead
Sr Research Scientist I Oncology Bioinformatics, Research Data Science
https://www.biospace.com/job/2886552/sr-research-scientist-i-oncology-bioinformatics-research-data-science
Regeneron
Assoc Computational Scientist - Molecular Profiling and Data Science
https://www.pharmaopportunities.com/assoc-computational-scientist-molecular-profiling-and-data-science-job-12120428/#google_vignette
Sanofi
Global Research Postdoctoral Fellow - AI for Patient Stratification and Precision Medicine
https://sanofi.wd3.myworkdayjobs.com/en-US/SanofiCareers/details/Global-Research-Postdoctoral-Fellow---AI-for-Patient-Stratification-and-Precision-Medicine_R2714796?q=transcriptomic
Abbvie
Senior Scientist II, Bioinformatics - Omics Emerging Technology
https://www.biospace.com/job/2896241/senior-scientist-ii-bioinformatics-omics-emerging-technology
Eli Lilly
https://www.linkedin.com/jobs/view/director-senior-director-computational-biology-at-eli-lilly-and-company-3784109633/
Director/Senior Director - Computational Biology
CNBC returns to giving NWBO pps in realtime. Chart not working very well though.
Hopefully the big fish get cancer, die and get eaten by the little fish.
Dr. Liau mentioned a lot about transcriptomic study in her publications. How is transcriptomic study related to cancer study? ChatGPT gave the reply.
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C44&q=Linda+Liau+%2B+Transcriptomic&btnG=
Cellular and transcriptional immune responses induced by neoadjuvant PD-1 blockade in glioblastoma patients
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154795
Transcriptomic characterization of GBM tumor and vascular cells and IBSP on patient-delived gliomasphere culture
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE186932
Agreed. I think they are both cancers that we could inject with DCVax
I still feel confident in my shares at Fidelity and have again added to my daughter's and my position to take it to a nice round figure for all of us. I believe that Fidelity will be able to deal with all share issues and no shares will be lost. In each of three trades I made today I put in limits at $.50 and in every case the trades were slightly below that price.
Gary
Trump and or Biden would say anything to get elected.
Below is a post that I'd made back in Nov 2018 re: what had happened to me when I tried to look into obtaining the physical certificates to some of my shares in one of my Schwab accounts. It may be helpful to look over for anyone considering taking that type of action.
Yep
Eventually the big fish need small fish to invest to steal money from . If small fish get too disheartened to invest then big fish will have to steal from each other
If Trump starts talking about financial market reform and specifically stomping out naked short selling, then he might pick up quite a bit of support from WSB Apes who otherwise might not be voting or even might currently side with Biden. Not trying to get political as I think both are unfit for office but we desperately need capital mkts reform IMO.
I was going to mention that I thought making a move like transferring shares from your brokerage to ComputerShare would probably make the shares untouchable and ensure that they are not being used for shorting - although I'm not sure if Computer Share still houses their share with the DTC (I honestly don't know and perhaps someone else knows the answer to that straight away, although I'm sure a little research would indicate whether this is the case or not). If they're still in the DTC, then that could potentially still be a problem, if you believe there is a large naked share position.
But again, if your shares are in a Roth, then unless you can transfer the entire Roth account to Computer Share, I don't see how you can move them out of the Roth and hold on to the ability to benefit from the potential tax advantages should the share price rise.
Citadel Securities blasts Trump Media CEO Nunes over DJT short-selling letter https://www.cnbc.com/2024/04/19/citadel-securities-blasts-trump-media-ceo-over-djt-short-sale-letter.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
GREAT IDEA...!!!
I'd love to sell some of those $1.52 shares I bought on that day (thinking the pps would GO UP on positive news).... and make a tidy profit on them...😃
Apparently these geniuses have no experience with pink sheet stocks
Haha. Glad I have that fraud on ignore. I think it's AF, thus the stupidity.
No sweat Dstock.
Lordy.Lordy…..hello .40’s (and lower)…..just as Pumpernickel predicted…….SOOOOO PREDICTABLE…….sooooooo easy to short………the pumpers are getting desperate……the “predictions” on this board are getting more and more DESPERATE…………. JUNK MANAGEMENT……. JUNK STOCK…….. DELUSIONAL POSTERS / SHAREHOLDERS…………….
Pumpernickel……. YuYU………LaLAAAAA………. YuLAYuLAYuuuuuuuuuuuuuuuuuu…………AAAAAAAAAAAAAAAAAAAAAAAAAAAAWWHHOOOOOOOOOOOOOOOOOOoooooooooooooooooooeeeeeeeeeeeeeeeeeeee!!!!!!!!!!!!!!!!
When the bough breaks, the cradle will fall...
That was probably ENZO Biochem...
I believe I remember this... At a friend's funeral, the daughter's husband told me the company had a cure for HIV and it was going to $100... It was $4+ at the time... I looked into it and just wasn't impressed, but watched it run within a couple of months to mid $30s. It then paused there for quite a while and then took off gaining ~ $10 to $15 a day for several days. I remember it breaking $100. Don't remember where it finally turned at... but I do remember being sick about it.
You know she works for UCLA , right?
Prediction and opinion.
MHRA: While DCVAX might have promise in the future, we are requesting a new P III double blind , randomized PFS trial with no external controls. We will continue to allow C Care use in the interim for the extremely limited people who opt for it.
Thanks.
JMHO
wouldn't transferring the shares to Computershare (our transfer agent) be the safest method to secure our shares while not bearing the risk of holding paper certs? Gamestop shareholders have en masse transferred > 30% of the float over to Computershare. Unfortunately our ever increasing float would make this battle of drying up the liquidity pool of legit shares difficult but we can protect our own positions.
Do you seriously believe your brokerage fiduciary has shares in your account that may not be validated as real?
That would be awesome, but if we do have to wait a bit longer I would love to see them announce approval on May 10th as a kick in the crotch to AF and all the other asswipes on the 2 yr anniversary of screwing over investors, NWBO, and GBM patients everywhere. That would be sweet justice!!!
when the short thugs and the MM accomplices are stealing cheap shares each trading day since the past several weeks in the 100s of thousands each day, wish the longs have enough dry powder; should also snatch some of those cheap shares. Hell to the shorts and heaven to the longs!
Shit!!!😳
Everyone is gambling.... not only on the whether or not the stock will rise... but whether or not the system will honor their purchase...
This is making me rethink my exit strategy.... maybe I should get out with a profit, but before the system breaks...
In all honesty, I really do feel sorry for people who lose money based on bad info. So sad.
George,
Pardon me for the typos.
4/27/24 is a Saturday...What is happening on Saturday?
Maybe the ASM is going to be a picnic. :)
Named same players too!
Out of curiosity, is Nemesis18 aka whosleftholdindabag a nice boss?
The reason I am asking is that Nemesis18 always likes his minions' posts over weekend. Nemesis18 must force his minions to work a lot over weekend.
Followers
|
1619
|
Posters
|
|
Posts (Today)
|
161
|
Posts (Total)
|
686114
|
Created
|
02/02/05
|
Type
|
Free
|
Moderators XenaLives sentiment_stocks CaptainObvious Poor Man - Doc logic JerryCampbell |
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.”
~ Winston Churchill
Stylized Dendritic Cell featured on NWBO board since 2015
- Dr. Linda Liau, PhD, MBA, Professor and Chair, Department of Neurosurgery, David Geffen School of Medicine at UCLA
Clinical Trials
DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind)
UK (MHRA): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
DE (Germany - PEI): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access)
Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label)
UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer
EU Clinical Trials for DCVax-L - Phase III
Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA - Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC
Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873)
Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma - Phase 2 (NCT03014804)
Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer (NCT0368765) - Phase 1 - Collaborator: Mayo Clinic
Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial - November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz
Cognate Bioservices - Owned by Charles River Labs
Website
Company Contact Info
Investor Relations:
Les Goldman (Company) (202) 841-7909 lgoldman@nwbio.com
Sign up for Northwest email list here (hit the subscribe to email list button in the lower right)
Company Headquarters
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814 (240) 497-9024
NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables them to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines.
Their lead product, DCVax-L, is currently in a 331-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.
Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.
They previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.
DCVAX Survival Stories & Testimonials
Alice - Metastic Merkel Cell patient from Florida - ASCO 2018
Brad Silver - GBM patient from Huntington Beach, California - ASCO 2018
Sarah Rigby - GBM patient from Hong Kong - ASCO 2018
Kristyn Power - daughter of GBM patient from Canada - ASCO 2018
Kat Charles - GBM patients from UK - ASCO 2018 - as related by her husband Jason (Kat's Cure)
Prospective patients may contact NW Bio at patients@nwbio.com
UCLA Jamil Newirth DCVax-Patient Video - 2015
Allan Butler Video - National Geographic Vice President - DCVax-Direct patient from Phase 1 Trial with Pancreatic Cancer
NWBO - Patients Sunday Dennis and Jami Newirth - Enrolled at UCLA - Vimeo, Uploaded approx. May 2015
NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015
NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson
NWBO GBM Brain Cancer Survival Story of Mark Pace
Presentations
UCLA Agreements
Prostrate
DCVax-Phase II
DCVax-Booster
Upcoming Events
Videos
Linda M. Liau, MD, PhD, MBA - April 24, 2019 at University of Washington, Neurosciences Institute
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |